Abivax SA (ABVX)
83.83
+1.73
(+2.11%)
USD |
NASDAQ |
Nov 18, 16:00
84.00
+0.17
(+0.20%)
After-Hours: 20:00
Abivax Enterprise Value : 6.232B for Nov. 18, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 18, 2026 | 6.232B |
| November 17, 2026 | 6.094B |
| November 16, 2026 | 6.215B |
| November 13, 2026 | 6.532B |
| November 12, 2026 | 6.741B |
| November 11, 2026 | 6.840B |
| November 10, 2026 | 6.725B |
| November 09, 2026 | 6.485B |
| November 06, 2026 | 6.384B |
| November 05, 2026 | 6.260B |
| November 04, 2026 | 6.684B |
| November 03, 2026 | 6.622B |
| November 02, 2026 | 6.319B |
| October 30, 2026 | 6.453B |
| October 29, 2026 | 6.650B |
| October 28, 2026 | 6.712B |
| October 27, 2026 | 6.485B |
| October 26, 2026 | 6.446B |
| October 23, 2026 | 6.566B |
| October 22, 2026 | 6.743B |
| October 21, 2026 | 7.003B |
| October 20, 2026 | 6.932B |
| October 19, 2026 | 6.525B |
| October 16, 2026 | 6.576B |
| October 15, 2026 | 6.915B |
| Date | Value |
|---|---|
| October 14, 2026 | 6.564B |
| October 13, 2026 | 6.423B |
| October 12, 2026 | 6.481B |
| October 09, 2026 | 6.577B |
| October 08, 2026 | 6.649B |
| October 07, 2026 | 6.486B |
| October 06, 2026 | 6.583B |
| October 05, 2026 | 6.863B |
| October 02, 2026 | 6.955B |
| October 01, 2026 | 7.132B |
| September 30, 2026 | 7.445B |
| September 29, 2026 | 7.403B |
| September 28, 2026 | 7.272B |
| September 25, 2026 | 6.809B |
| September 24, 2026 | 7.114B |
| September 23, 2026 | 7.055B |
| September 22, 2026 | 7.387B |
| September 21, 2026 | 7.798B |
| September 18, 2026 | 7.925B |
| September 17, 2026 | 8.081B |
| September 16, 2026 | 7.701B |
| September 15, 2026 | 8.055B |
| September 14, 2026 | 8.607B |
| September 11, 2026 | 9.011B |
| September 10, 2026 | 8.796B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cocrystal Pharma, Inc. | 15.13M |
| CNBX Pharmaceuticals, Inc. | 1.305M |
| GB Sciences, Inc. | -- |
| Invion Ltd. | -- |
| Arvinas, Inc. | -107.69M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -136.54M |
| Total Expenses (Quarterly) | 136.54M |
| EPS Diluted (Quarterly) | -1.714 |
| Earnings Yield | -7.28% |
| Normalized Earnings Yield | -5.998 |